BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15797447)

  • 1. Soluble mediators of inflammation during tumor development.
    Robinson SC; Coussens LM
    Adv Cancer Res; 2005; 93():159-87. PubMed ID: 15797447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation: gearing the journey to cancer.
    Kundu JK; Surh YJ
    Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments.
    Rabinovich GA; Ilarregui JM
    Immunol Rev; 2009 Jul; 230(1):144-59. PubMed ID: 19594634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelium and immune responses: implications for inflammation and angiogenesis.
    Szekanecz Z; Koch AE
    Rheum Dis Clin North Am; 2004 Feb; 30(1):97-114. PubMed ID: 15061570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
    Allavena P; Sica A; Garlanda C; Mantovani A
    Immunol Rev; 2008 Apr; 222():155-61. PubMed ID: 18364000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and its relationship to inflammatory mediators.
    Angelo LS; Kurzrock R
    Clin Cancer Res; 2007 May; 13(10):2825-30. PubMed ID: 17504979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells.
    Chen R; Alvero AB; Silasi DA; Steffensen KD; Mor G
    Oncogene; 2008 Jan; 27(2):225-33. PubMed ID: 18176604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticles as mediators of cellular cross-talk in inflammatory disease.
    Distler JH; Huber LC; Gay S; Distler O; Pisetsky DS
    Autoimmunity; 2006 Dec; 39(8):683-90. PubMed ID: 17178565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of late normal tissue injury.
    Brush J; Lipnick SL; Phillips T; Sitko J; McDonald JT; McBride WH
    Semin Radiat Oncol; 2007 Apr; 17(2):121-30. PubMed ID: 17395042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytokines: mediators linking adipose tissue, inflammation and immunity.
    Tilg H; Moschen AR
    Nat Rev Immunol; 2006 Oct; 6(10):772-83. PubMed ID: 16998510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous control and modulation of inflammation.
    Ferencík M; Stvrtinová V
    Folia Biol (Praha); 1996; 42(1-2):47-55. PubMed ID: 8831026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.
    Mantovani A; Sica A; Allavena P; Garlanda C; Locati M
    Hum Immunol; 2009 May; 70(5):325-30. PubMed ID: 19236898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment.
    O'Hayre M; Salanga CL; Handel TM; Allen SJ
    Biochem J; 2008 Feb; 409(3):635-49. PubMed ID: 18177271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.
    Bronte V; Cingarlini S; Marigo I; De Santo C; Gallina G; Dolcetti L; Ugel S; Peranzoni E; Mandruzzato S; Zanovello P
    Immunol Invest; 2006; 35(3-4):327-57. PubMed ID: 16916757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation, proteases and cancer.
    van Kempen LC; de Visser KE; Coussens LM
    Eur J Cancer; 2006 Apr; 42(6):728-34. PubMed ID: 16524717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, a key event in cancer development.
    Lu H; Ouyang W; Huang C
    Mol Cancer Res; 2006 Apr; 4(4):221-33. PubMed ID: 16603636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-23 promotes tumour incidence and growth.
    Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
    Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.